n,n-dimethylarginine has been researched along with Multiple Sclerosis, Relapsing-Remitting in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abusoglu, G; Abusoglu, S; Aydemir, HY; Ekmekci, AH; Isık, SMT; Onmaz, DE; Ozturk, S; Sivrikaya, A; Unlu, A | 1 |
| Basic, J; Cvetkovic, T; Ilic, A; Ljubisavljevic, S; Pavlovic, D; Pavlovic, R; Stojanovic, I; Stukalov, M; Vojinovic, S | 1 |
2 other study(ies) available for n,n-dimethylarginine and Multiple Sclerosis, Relapsing-Remitting
| Article | Year |
|---|---|
Serum ADMA levels were positively correlated with EDSS scores in patients with multiple sclerosis.
Topics: Adult; Arginine; Female; Humans; Male; Multiple Sclerosis, Relapsing-Remitting; Nitric Oxide; Severity of Illness Index | 2021 |
INF-β1b therapy modulates L-arginine and nitric oxide metabolism in patients with relapse remittent multiple sclerosis.
Topics: Adult; Arginase; Arginine; Biomarkers; Drug Monitoring; Female; Follow-Up Studies; Humans; Inflammation; Interferon beta-1b; Interferon-beta; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Nitrates; Nitric Oxide; Nitrites; Nitroso Compounds; Severity of Illness Index; Sulfhydryl Compounds; Tyrosine; Young Adult | 2012 |